Newly Launched Eir Ventures To Target ‘Early Nordic Opportunities’

Founders Plan To Invest In Region’s ‘Underappreciated’ Life Sciences

Scandinavia
Fund is equipped with initial €76m ($85m) for targeted investments • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip